Share-based Payment Arrangement, Expense of IGC Pharma, Inc. from 31 Mar 2018 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
IGC Pharma, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Mar 2018 to 30 Jun 2025.
  • IGC Pharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Jun 2025 was $452,000, a 12% increase year-over-year.
  • IGC Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $1,640,000, a 7.5% decline from 2023.
  • IGC Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1,773,000, a 38% decline from 2022.
  • IGC Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2,843,000, a 29% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

IGC Pharma, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $452,000 +$50,000 +12% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2026 Q1
Q2 2024 $402,000 +$45,000 +13% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2026 Q1
Q2 2023 $357,000 -$795,000 -69% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2025 Q1
Q2 2022 $1,152,000 +$1,027,000 +822% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2024 Q1
Q2 2021 $125,000 -$41,000 -25% 01 Apr 2021 30 Jun 2021 10-Q 05 Aug 2022 2023 Q1
Q2 2020 $166,000 -$42,000 -20% 01 Apr 2020 30 Jun 2020 10-Q 11 Aug 2021 2022 Q1
Q2 2019 $208,000 +$46,000 +28% 01 Apr 2019 30 Jun 2019 10-Q 19 Aug 2020 2021 Q1
Q4 2018 $13,000 01 Oct 2018 31 Dec 2018 10-Q 10 Feb 2020 2020 Q3
Q2 2018 $162,000 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019 2020 Q1

IGC Pharma, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,640,000 -$133,000 -7.5% 01 Apr 2024 31 Mar 2025 10-K 27 Jun 2025 2025 FY
2023 $1,773,000 -$1,070,000 -38% 01 Apr 2023 31 Mar 2024 10-K 27 Jun 2025 2025 FY
2022 $2,843,000 +$646,000 +29% 01 Apr 2022 31 Mar 2023 10-K 24 Jun 2024 2024 FY
2021 $2,197,000 +$1,539,000 +234% 01 Apr 2021 31 Mar 2022 10-K 07 Jul 2023 2023 FY
2020 $658,000 -$112,000 -15% 01 Apr 2020 31 Mar 2021 10-K 23 Jun 2022 2022 FY
2019 $770,000 +$160,000 +26% 01 Apr 2019 31 Mar 2020 10-K 14 Jun 2021 2021 FY
2018 $610,000 +$34,000 +5.9% 01 Apr 2018 31 Mar 2019 10-K 13 Jul 2020 2020 FY
2017 $576,000 01 Apr 2017 31 Mar 2018 10-K 14 Jun 2019 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.